AA
TVGN icon

Ancora Advisors’s Tevogen Bio Holdings TVGN Stock Holding History

Ancora Advisors’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-248
Closed -$124K – 2193
2022
Q2 		$124K Hold
248
– – ﹤0.01% 899
2022
Q1 		$124K Buy
+248
New +$123K ﹤0.01% 953

Other funds holding TVGN

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

Ancora Advisors's TVGN Position: Q3 2022 in Review

Ancora Advisors sold out of Tevogen Bio Holdings (TVGN) in Q3 2022, closing a stake of 248 shares — an estimated $124K sold.

Ancora Advisors first reported a position in TVGN in Q1 2022 and held it in 2 quarters. The position peaked at $124K in Q2 2022. 62 funds tracked by Wall St. Rank hold TVGN as of Q3 2022.

  • Ancora Advisors reported no remaining Tevogen Bio Holdings position as of Q3 2022 after selling out during the quarter.
  • Ancora Advisors sold 248 Tevogen Bio Holdings shares in Q3 2022, an estimated $124K.
  • Ancora Advisors first reported a position in Tevogen Bio Holdings in Q1 2022 and held it in 2 quarters.
  • Ancora Advisors's Tevogen Bio Holdings position peaked at $124K in Q2 2022.
  • 62 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q3 2022.

Based on Ancora Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.